Typhoid-Paratyphoid Vaccines

• 

  Subject Areas on Research

  • Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharide. 
  • Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen. 
  • Estimands and inference in cluster-randomized vaccine trials. 
  • Facility-based disease surveillance and Bayesian hierarchical modeling to estimate endemic typhoid fever incidence, Kilimanjaro Region, Tanzania, 2007-2018. 
  • IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model. 
  • Oral typhoid vaccine Ty21a. 
  • Positive antibody response to vaccination in adolescence predicts lower C-reactive protein concentration in young adulthood in the Philippines. 
  • Rapid diagnosis of typhoid fever by enzyme-linked immunosorbent assay detection of Salmonella serotype typhi antigens in urine. 
  • The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries. 
  • Vi-specific serological correlates of protection for typhoid fever.